An Open-Label, Phase 1b Study of ACP-196 Alone or in Combination with Rituximab in Subjects with folicular Lymphoma

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date8/4/158/3/16

    Funding

    • Acerta Pharma BV: $6,627.00